Denosumab and Teriparatide Study (DATA-HD and DATA-EX)
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 27 Apr 2017
At a glance
- Drugs Denosumab (Primary) ; Teriparatide (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Acronyms DATA-HD
- 30 Nov 2016 Planned primary completion date changed from 1 Oct 2019 to 1 Dec 2019.
- 30 Nov 2016 Status changed from recruiting to active, no longer recruiting.
- 22 Mar 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Oct 2019, according to ClinicalTrials.gov record.